Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

8.77
+0.71508.88%
Volume:942.88K
Turnover:8.11M
Market Cap:578.94M
PE:-2.33
High:8.95
Open:8.14
Low:8.13
Close:8.06
52wk High:16.19
52wk Low:5.46
Shares:66.01M
Float Shares:57.34M
Volume Ratio:1.04
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7652
EPS(LYR):-3.7593
ROE:-137.63%
ROA:-21.20%
PB:8.07
PE(LYR):-2.33

Loading ...

Regenxbio Inc. : H.c. Wainwright Cuts Target Price to $21 from $23

THOMSON REUTERS
·
59 mins ago

Regenxbio Appoints Greg Ciongoli to Board of Directors

Reuters
·
Yesterday

Regenxbio Strengthens Board of Directors with Appointment of Greg Ciongoli

THOMSON REUTERS
·
Yesterday

Regenxbio Inc. : Clear Street Cuts Target Price to $32 from $45

THOMSON REUTERS
·
Yesterday

Regenxbio is Maintained at Outperform by Baird

Dow Jones
·
Yesterday

Regenxbio price target lowered to $32 from $45 at Clear Street

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Ansell (OtherANSLF)

TIPRANKS
·
Yesterday

Top Midday Decliners

MT Newswires Live
·
Yesterday

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

TIPRANKS
·
Aug 24

Regenxbio Stock Sinks 22% Following Surprise Finding in Gene Therapy Trial

Dow Jones
·
Aug 24

Regenxbio Shares Down 25% Premarket After FDA Places Clinical Hold on Co's Gene Therapy for Hunter Syndrome

THOMSON REUTERS
·
Aug 24

Regenxbio reports FDA placed clinical hold on RGX-121

TIPRANKS
·
Aug 24

FDA Places Clinical Hold on Regenxbio RGX-121 Gene Therapy for Hunter Syndrome After Spine MRI Findings

Reuters
·
Aug 24

Regenxbio - Co and Ns Pharma Evaluating Additional Data for Rgx-121

THOMSON REUTERS
·
Aug 24

Regenxbio - FDA Places Clinical Hold on Rgx-121 After Spine Mri Findings

THOMSON REUTERS
·
Aug 24

Regenxbio - Does not Expect to Resubmit Rgx-121 Bla in Near Term

THOMSON REUTERS
·
Aug 24

NASDAQ Trade Halt Halt News Pending at 07:00 Am

Reuters
·
Aug 24

Trump Picks White House Adviser Heidi Overton to Run FDA, Source Says

Reuters
·
Aug 19

Regenxbio Price Target Cut to $23.00/Share from $26.00 by HC Wainwright & Co.

Dow Jones
·
Aug 10

Regenxbio price target lowered to $23 from $26 at H.C. Wainwright

TIPRANKS
·
Aug 10